tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Adagene files to sell 10.625M ordinary shares or 8.5M ADSs for holders
PremiumThe FlyAdagene files to sell 10.625M ordinary shares or 8.5M ADSs for holders
2M ago
Adagene says first patient dosed in Phase 2 study of muzastotug, KEYTRUDA
Premium
The Fly
Adagene says first patient dosed in Phase 2 study of muzastotug, KEYTRUDA
2M ago
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
Premium
Company Announcements
Tempest Therapeutics and Adagene’s Promising Advances in Liver Cancer Treatment
2M ago
Adagene’s Promising Position in Next-Gen CTLA-4 Class: Buy Rating Reinforced by Clinical Success and Strategic Optionality
PremiumRatingsAdagene’s Promising Position in Next-Gen CTLA-4 Class: Buy Rating Reinforced by Clinical Success and Strategic Optionality
4M ago
Adagene’s Strategic Partnerships and Regulatory Milestones Drive Buy Rating
Premium
Ratings
Adagene’s Strategic Partnerships and Regulatory Milestones Drive Buy Rating
4M ago
Adagene price target lowered to $7 from $8 at H.C. Wainwright
Premium
The Fly
Adagene price target lowered to $7 from $8 at H.C. Wainwright
4M ago
Adagene and ConjugateBio partner to develop antibody drug conjugate
PremiumThe FlyAdagene and ConjugateBio partner to develop antibody drug conjugate
5M ago
Adagene Secures $25 Million Investment from Sanofi to Advance Cancer Therapies
Premium
Company Announcements
Adagene Secures $25 Million Investment from Sanofi to Advance Cancer Therapies
6M ago
Adagene announces up to $25M strategic investment from Sanofi
Premium
The Fly
Adagene announces up to $25M strategic investment from Sanofi
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100